NCT07659652Not yet recruiting
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Prospective Evaluation of Quality of Life in Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
Source: ClinicalTrials.gov · Last updated 24 Aug 2026
Brief summary (registry, in English)
Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 9 Jun 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- University of California, San Francisco
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07659652
What you commit to
- Study type: Observational
- Planned participants: 200
- From 15 Oct 2026 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who are not on any anticancer therapy and are not planning to start any anticancer therapy will be excluded from the study.
Who the study is looking for
- Be male or female 18 years of age or older.
- Have stage 4 (metastatic) breast cancer with spread to the brain parenchyma and/or leptomeninges.
- Have the intention to start or continue anticancer therapy.
- Be able to provide informed consent.
- Be able to speak and read English.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.